Spero Therapeutics Inc - רווח למניה אחת ב-12 החודשים האחרונים SPRO

This daily price chart for Spero Therapeutics (SPRO) on the GURU.Markets platform, where EPS is 38.50, reflects the price action of a biopharmaceutical company whose antibiotic supplies depend on the stability of Asian logistics. A team of top-tier medical professionals is developing socially critical medicines in exchange for stock options. However, strict FDA oversight and inconsistent payments from counterparties render the company's cash flows volatile.
sperotherapeutics.com - פילוחים אנליטיים ומדדי מפתח (SPRO)

To minimize risks when building a position, it is essential to track the rolling year earnings per share trend, which identifies structural shifts in business profitability by measuring the annual growth of EPS TTM. For Spero Therapeutics (SPRO), this indicator reflects the monetization of unique antibiotics against resistant infections, confirming the company's pricing power and the fundamental stability of its operating model.